Skip to content
Search

Latest Stories

Labour with Nuffield Health to aid thousands of NHS staff with joint pain return to work

Labour with Nuffield Health to aid thousands of NHS staff with joint pain return to work
Nurses accounted for 52,000 of sick days, doctors for 3,500, both up since 2019 as per the Labour report

“Record long NHS waits are forcing huge numbers of people out of work, including doctors and nurses," said Wes Streeting MP, Labour’s Shadow Health and Social Care Secretary as Labour announced a new partnership with Nuffield Health today to tackle joint pain issues among NHS staff and reducing waiting lists.

Musculoskeletal problems, including back, knee, hip, and neck pain, are the second leading cause of NHS staff absences, surpassed only by mental health issues.


In December 2023 alone, NHS workers missed a record 198,000 days due to these issues, marking a 13 per cent increase from the 174,000 days recorded in December 2019.

Nurses and health visitors accounted for 52,000 of these days, up from 47,000 pre-pandemic, while doctors took 3,500 days off, a 9 per cent increase from 2019.

The partnership with Nuffield Health will provide up to 4,000 extra places for NHS staff in Nuffield Health’s Joint Pain Programme at no cost.

This programme aims to help staff suffering from joint pain remain in or return to work, thus addressing both staff shortages and patient care backlogs.

Labour also has other initiatives, such as collaborations with Virgin/O2 to help children with type-1 diabetes and high street opticians to reduce eye test waiting lists.

"NHS staff can’t treat patients if they are in debilitating pain themselves. Keir Starmer’s mission-driven government will get NHS staff treated and back to work to help clear the backlog," added Streeting.

"We will care for carers, so they can care for us," he added.

"Labour will harness all the talents of our country’s public sector, business, and civil society to make our NHS fit for the future," he continued.

Jill Pritchard, Nuffield Health's Hospitals Commercial Director, highlighted the importance of this initiative, stating:

"Low-impact, supported exercise can be transformative and accessible, yet its benefits are not widely understood, leaving many people without the support they need."

"At Nuffield Health, our community rehabilitation programmes are leading the charge with 10,000 people benefiting each year. We welcome the opportunity to work with Labour to extend this vital resource," she continued.

Ishmael Beckford, chair of the Chartered Society of Physiotherapy, praised the initiative to cut long waits for NHS services leading to more complex problems.

He said: "We know that the greater the amount of time someone is off work, the less likely they are ever to return."

Calling it a "double blow when the person waiting is an NHS clinician", Beckford added that NHS staff desperately need to be "well enough to work providing crucial services, especially during a workforce crisis."

The partnership is poised to support NHS staff health and wellbeing, helping them return to work and continue delivering essential services, ultimately benefiting the entire healthcare system.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less